These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12651209)

  • 1. Dihydropyrimidine dehydrogenase circadian rhythm in mouse liver: comparison between enzyme activity and gene expression.
    Porsin B; Formento JL; Filipski E; Etienne MC; Francoual M; Renée N; Magné N; Lévi F; Milano G
    Eur J Cancer; 2003 Apr; 39(6):822-8. PubMed ID: 12651209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian expression of dihydropyrimidine dehydrogenase, thymidylate synthase, c-myc and p53 mRNA in mouse liver tissue.
    Wu MW; Xian LJ; Li XM; Pasquale I; Francis L
    Ai Zheng; 2004 Mar; 23(3):235-42. PubMed ID: 15025949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls.
    Raida M; Kliche KO; Schwabe W; Häusler P; Clement JH; Behnke D; Höffken K
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):96-102. PubMed ID: 11862480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNA in mouse liver.
    Shimizu M; Tamura T; Yamada Y; Akiyama Y; Saijo N; Nishio K
    Jpn J Cancer Res; 2001 May; 92(5):554-61. PubMed ID: 11376565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapy.
    Harris BE; Song RL; He YJ; Soong SJ; Diasio RB
    Biochem Pharmacol; 1988 Dec; 37(24):4759-62. PubMed ID: 3202908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy.
    Zhang R; Lu Z; Liu T; Soong SJ; Diasio RB
    Cancer Res; 1993 Jun; 53(12):2816-22. PubMed ID: 8504424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M; Takechi T; Okabe H; Fukushima M
    Clin Cancer Res; 1999 Apr; 5(4):883-9. PubMed ID: 10213225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between intratumoral dihydropyrimidine dehydrogenase activity and gene expression in human colorectal cancer.
    Uetake H; Ichikawa W; Takechi T; Fukushima M; Nihei Z; Sugihara K
    Clin Cancer Res; 1999 Oct; 5(10):2836-9. PubMed ID: 10537350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Takechi T; Okabe H; Fukushima M; Kitajima M
    Jpn J Cancer Res; 2000 Jan; 91(1):105-12. PubMed ID: 10744051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythm of dihydrouracil/uracil ratios in biological fluids: a potential biomarker for dihydropyrimidine dehydrogenase levels.
    Jiang H; Lu J; Ji J
    Br J Pharmacol; 2004 Feb; 141(4):616-23. PubMed ID: 14744810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of dihydropyrimidine dehydrogenase in primary colorectal cancer and liver metastasis--a relationship between mRNA levels in cancer cells and protein levels in cancerous tissue and effect of 5-fluorouracil].
    Ishibashi K; Sobajima J; Ishiguro T; Ohsawa T; Okada N; Miyazaki T; Yokoyama M; Inokuma S; Ishida H
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2232-5. PubMed ID: 20037380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dihydropyrimidine dehydrogenase gene expression in patients with hepatic metastases from colorectal cancer].
    Shirota Y; Ichikawa W; Yamada H; Uetake H; Nihei Z; Sugihara K
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1729-31. PubMed ID: 10560382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion.
    Harris BE; Song R; Soong SJ; Diasio RB
    Cancer Res; 1990 Jan; 50(1):197-201. PubMed ID: 2293556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.
    Fujiwara H; Terashima M; Irinoda T; Takagane A; Abe K; Kashiwaba M; Oyama K; Takahashi M; Maesawa C; Saito K; Takechi T; Fukushima M
    Jpn J Cancer Res; 2002 Dec; 93(12):1342-50. PubMed ID: 12495474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of dihydropyrimidine dehydrogenase gene expression in regenerating mouse liver.
    Yamada H; Fukushima M; Koizumi K; Katakura H; Nakanishi H; Teshima S; Kamiyama Y; Ikenaka K
    Int J Oncol; 2003 Feb; 22(2):359-64. PubMed ID: 12527935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Link between dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells and liver.
    Chazal M; Etienne MC; Renée N; Bourgeon A; Richelme H; Milano G
    Clin Cancer Res; 1996 Mar; 2(3):507-10. PubMed ID: 9816197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyrimidine dehydrogenase activity of cancerous and non-cancerous tissues in liver and large intestine.
    Ikeguchi M; Hirooka Y; Makino M; Kaibara N
    Oncol Rep; 2001; 8(3):621-5. PubMed ID: 11295091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
    Salonga D; Danenberg KD; Johnson M; Metzger R; Groshen S; Tsao-Wei DD; Lenz HJ; Leichman CG; Leichman L; Diasio RB; Danenberg PV
    Clin Cancer Res; 2000 Apr; 6(4):1322-7. PubMed ID: 10778957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of dihydropyrimidine dehydrogenase in colorectal cancer.
    Johnston SJ; Ridge SA; Cassidy J; McLeod HL
    Clin Cancer Res; 1999 Sep; 5(9):2566-70. PubMed ID: 10499634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa.
    Miyamoto S; Ochiai A; Boku N; Ohtsu A; Tahara M; Yoshida S; Okabe H; Takechi T; Fukushima M
    Int J Oncol; 2001 Apr; 18(4):705-13. PubMed ID: 11251164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.